Effect of Mobile Communication on Childhood Cataract Follow-up Adherence

NCT01417819 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 258

Last updated 2011-08-30

No results posted yet for this study

Summary

Rigorous and regular follow-up is essential to successful management of childhood cataract, but it is often ignored by parents and especially difficult to be delivered in China, such an average-medical-resource-limited country.

Health programmes that use mobile communication technologies are emerging with the aim of strengthening health systems.

The investigators aimed to assess whether mobile phone short message service (SMS) for parents of cataract children involved in the Childhood Cataract Program of Ministry of Health of China (CCPMOH) improved follow-up adherence and detection rate of the timing of surgery, postoperative complications and necessary replacement of glasses.

Conditions

  • Cataract

Interventions

OTHER

Mobile short message service

Mobile short message service reminder for appointments of parents of cataract children

Sponsors & Collaborators

  • Ministry of Health, China

    collaborator OTHER_GOV
  • Sun Yat-sen University

    lead OTHER

Principal Investigators

  • Haotian Lin, M.D., Ph.D. · Zhongshan Ophthalmic Center, Sun Yat-sen University

  • Yizhi Liu, M.D., Ph.D. · Zhongshan Ophthalmic Center, Sun Yat-sen University

  • Weirong Cheng, M.D. · Zhongshan Ophthalmic Center, Sun Yat-sen University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2011-08-31
Completion
2011-08-31

Countries

  • China

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01417819 on ClinicalTrials.gov